Cargando…
A Radiosensitivity Gene Signature and XPO1 Predict Clinical Outcomes for Glioma Patients
Objective: Glioma is the most common and fatal primary brain tumor that has a high risk of recurrence in adults. Identification of predictive biomarkers is necessary to optimize therapeutic strategies. This study investigated the predictive efficacy of a previously identified radiosensitivity signat...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308508/ https://www.ncbi.nlm.nih.gov/pubmed/32612949 http://dx.doi.org/10.3389/fonc.2020.00871 |